Frequencies of CD33+CD11b+HLA-DRCD14CD66b+ and CD33+CD11b+HLA-DRCD14+CD66b Cells in Peripheral Blood as Severity Immune Biomarkers in COVID-19
Front.med.
;
7: 1-2, 2020.
Article
in Portuguese
| LILACS, CONASS, ColecionaSUS, SES-SP, SESSP-IALPROD, SES-SP
| ID: biblio-1416578
ABSTRACT
Common clinical features of patients with Coronavirus disease-2019 (COVID-19) vary from fever, to acute severe respiratory distress syndrome. Several laboratory parameters are reported as indicators of COVID-19 severity. We hereby describe the possible novel severity biomarkers for COVID-19, CD11b+CD33+HLA-DR-CD14+ cells and CD11b+CD33+HLA-DR-CD66b+ cells.
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Blood
/
HLA-DR Antigens
/
Coronavirus
/
Fever
Language:
Portuguese
Journal:
Front.med.
Year:
2020
Type:
Article
Institution/Affiliation country:
Departamento de Dermatologia, Faculdade de Medicina FMUSP/BR
/
Departamento de Imunologia, Instituto de Ciências Biomédicas/BR
/
Departamento de Patologia, Faculdade de Medicina FMUSP/BR
/
Laboratorio de Dermatologia e Imunodeficiencias (LIM-56)/BR
/
Technical Division of Medical Biology, Immunology Center/BR
Similar
MEDLINE
...
LILACS
LIS